Gibson Diagnostic Labs

Gibson Diagnostic Labs is a private U.S. clinical diagnostics company that operates a high-complexity laboratory serving physicians, counselors, clinicians, and patients. The company provides a menu of laboratory-developed and clinical diagnostic services spanning cancer genetics, infectious disease testing, pharmacogenetics, toxicology, and COVID-19 testing. Its business is centered on delivering clinically actionable data intended to support prevention, diagnosis, treatment selection, and personalized care. Gibson positions itself as a service-focused diagnostics provider with CLIA certification and COLA accreditation, and appears to commercialize testing services rather than therapeutics. The company primarily serves healthcare providers across multiple specialties including oncology, pain management, behavioral health, internal medicine, cardiology, gastroenterology, genetics, and women's health.